Literature DB >> 25173545

Diagnostic accuracy of multidetector computed tomography coronary angiography in 325 consecutive patients referred for transcatheter aortic valve replacement.

Daniele Andreini1, Gianluca Pontone2, Saima Mushtaq2, Antonio L Bartorelli3, Giovanni Ballerini2, Erika Bertella2, Chiara Segurini2, Edoardo Conte2, Andrea Annoni2, Andrea Baggiano2, Alberto Formenti2, Laura Fusini2, Gloria Tamborini2, Francesco Alamanni3, Cesare Fiorentini3, Mauro Pepi2.   

Abstract

BACKGROUND: Multidetector computed tomography (MDCT) provides detailed assessment of valve annulus and iliofemoral vessels in transcatheter aortic valve replacement (TAVR) patients. However, data on diagnostic performance of MDCT coronary angiography (MDCT-CA) are scarce. The aim of the study is to assess diagnostic performance of MDCT for coronary artery evaluation before TAVR.
METHODS: A total of 325 consecutive patients (234 without previous myocardial revascularization, 49 with previous coronary stenting, and 42 with previous coronary artery bypass graft [CABG]) underwent invasive coronary angiography and MDCT before TAVR. MDCT-CA was performed using the same data set dedicated to standard MDCT aortic annulus evaluation. Multidetector computed tomography-CA evaluability and diagnostic accuracy in comparison with invasive coronary angiography as criterion standard were assessed.
RESULTS: The MDCT-CA evaluability of native coronaries was 95.6%. The leading cause of unevaluability was beam-hardening artifact due to coronary calcifications. In a segment-based analysis, MDCT-CA showed sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy for detecting ≥50% stenosis of 91%, 99.2%, 83.4%, 99.6% and 98.8%, respectively. The MDCT-CA evaluability of coronary stents was 82.1%. In a segment-based analysis, MDCT-CA showed sensitivity, specificity, PPV, NPV, and accuracy for detecting ≥50% in-stent restenosis of 94.1%, 86.7%, 66.7%, 98.1%, and 88.3%, respectively. All CABGs were correctly assessed by MDCT-CA. In a patient-based analysis, MDCT-CA showed sensitivity, specificity, PPV, NPV, and accuracy of 89.7%, 90.8%, 80.6%, 95.4%, and 90.5%, respectively.
CONCLUSIONS: Multidetector computed tomography-CA allows to correctly rule out the presence of significant native coronary artery stenosis, significant in-stent restenosis, and CABG disease in patients referred for TAVR.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25173545     DOI: 10.1016/j.ahj.2014.04.022

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  17 in total

Review 1.  Transcatheter Aortic Valve Replacement: Comprehensive Review and Present Status.

Authors:  Sameer Arora; Jacob A Misenheimer; Radhakrishnan Ramaraj
Journal:  Tex Heart Inst J       Date:  2017-02-01

2.  Routine CT angiography to detect severe coronary artery disease prior to transcatheter aortic valve replacement.

Authors:  S Chava; G Gentchos; A Abernethy; B Leavitt; E Terrien; H L Dauerman
Journal:  J Thromb Thrombolysis       Date:  2017-08       Impact factor: 2.300

Review 3.  Percutaneous Coronary Intervention Pre-TAVR: Current State of the Evidence.

Authors:  Lukas S Keller; Vassili Panagides; Jules Mesnier; Jorge Nuche; Josep Rodés-Cabau
Journal:  Curr Cardiol Rep       Date:  2022-05-27       Impact factor: 3.955

4.  Clinical applications of cardiac computed tomography: a consensus paper of the European Association of Cardiovascular Imaging-part II.

Authors:  Gianluca Pontone; Alexia Rossi; Marco Guglielmo; Marc R Dweck; Oliver Gaemperli; Koen Nieman; Francesca Pugliese; Pal Maurovich-Horvat; Alessia Gimelli; Bernard Cosyns; Stephan Achenbach
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2022-03-22       Impact factor: 9.130

Review 5.  SCCT 2021 Expert Consensus Document on Coronary Computed Tomographic Angiography: A Report of the Society of Cardiovascular Computed Tomography.

Authors:  Jagat Narula; Y Chandrashekhar; Amir Ahmadi; Suhny Abbara; Daniel S Berman; Ron Blankstein; Jonathon Leipsic; David Newby; Edward D Nicol; Koen Nieman; Leslee Shaw; Todd C Villines; Michelle Williams; Harvey S Hecht
Journal:  J Cardiovasc Comput Tomogr       Date:  2020-11-20

6.  Feasibility and Comparison of Resting Full-Cycle Ratio and Computed Tomography Fractional Flow Reserve in Patients with Severe Aortic Valve Stenosis.

Authors:  Hendrik Wienemann; Marcel C Langenbach; Victor Mauri; Maryam Banazadeh; Konstantin Klein; Christopher Hohmann; Samuel Lee; Isabel Breidert; Alexander Hof; Kaveh Eghbalzadeh; Elmar Kuhn; Marcel Halbach; David Maintz; Stephan Baldus; Alexander Bunck; Matti Adam
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-14

Review 7.  Challenges in Diagnosis and Functional Assessment of Coronary Artery Disease in Patients With Severe Aortic Stenosis.

Authors:  Srdjan Aleksandric; Marko Banovic; Branko Beleslin
Journal:  Front Cardiovasc Med       Date:  2022-03-11

Review 8.  Diagnostic accuracy of coronary computed tomography angiography for the evaluation of obstructive coronary artery disease in patients referred for transcatheter aortic valve implantation: a systematic review and meta-analysis.

Authors:  Marco Gatti; Guglielmo Gallone; Vittoria Poggi; Francesco Bruno; Alessandro Serafini; Alessandro Depaoli; Ovidio De Filippo; Federico Conrotto; Fatemeh Darvizeh; Riccardo Faletti; Gaetano Maria De Ferrari; Paolo Fonio; Fabrizio D'Ascenzo
Journal:  Eur Radiol       Date:  2022-02-22       Impact factor: 7.034

Review 9.  The Pivotal Role of Imaging in TAVR Procedures.

Authors:  Caroline Bleakley; Mark J Monaghan
Journal:  Curr Cardiol Rep       Date:  2018-02-12       Impact factor: 2.931

10.  Statement from the North American Society for Cardiovascular Imaging on imaging strategies to reduce the scarcity of healthcare resources during the COVID-19 outbreak.

Authors:  Gregory Kicska; Diana E Litmanovich; Karen G Ordovas; Phillip M Young; Carole Dennie; Quynh A Truong; Suhny Abbara; Jacobo Kirsch
Journal:  Int J Cardiovasc Imaging       Date:  2020-05-30       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.